Ep. 184 - Live from AIS 2025: Alon Bloomenfeld of Raziel Therapeutics
Description
What if fat loss could be achieved without impacting metabolism? Recorded live at AIS 2025, Dr. Grant Stevens speaks with Alon Bloomenfeld, Executive Chair of Raziel Therapeutics, about a new class of injectable fat reduction—one that works locally, not systemically.
Unlike semaglutide or other metabolic treatments, this lipophilic compound directly destroys fat cells at the site of injection, offering a highly targeted, non-surgical solution for body contouring. With FDA Phase III trials underway, Bloomenfeld shares what sets this breakthrough apart.
» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/
The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/
Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/
United States
